Background Drug provocation test (DPT) represents the gold standard for the diagnosis of drug allergy. A DPT can be performed in a single-blind placebo-controlled manner. In anxiety and depressive disorders, patients need to be evaluated to understand the nature of placebo reactions. Objective The aim of this study was to evaluate the psychological profile of patients with reactions to placebo during a DPT. Methods We consecutively enrolled patients with suspected drug allergy undergoing a DPT preceded by the administration of the placebo. All patients underwent the Hospital Anxiety and Depression Scale (HADS), a questionnaire aimed to identify anxiety and depression, before the challenge test. Results A total of 196 patients were enrolled into this study: 8 (4%) patients resulted positive to the DPT, 60 (30.6%) demonstrated anxiety or depression based on the HADS, and 54 had at least 1 placebo reaction during drug provocation. There were statically significant correlations between the positivity of the HADS and the finding of a placebo reaction (Fisher’s exact test: P < .001), and between the latter and a history of severe reactions to drug (Fisher’s exact test: P < .001). Conclusions There is a significant and strong correlation between the loss of psychic equilibrium and the development of a placebo reaction during a DPT. We suggest the use the HADS or other validated questionnaire in clinical practice before a DPT to evaluate the possible psychiatric components.
Anxiety and Depression Effects during Drug Provocation Test / L.M. Losappio, A. Cappai, A. Arcolaci, I. Badiu, P. Bonadonna, E. Boni, C. Bussolino, M. Caminati, P. Galati, E. Heffler, R. Intravaia, M. Mauro, I. Massaro, A. Romano, G. Rumi, A. Parolo, S. Pizzimenti, M. Nichelatti, E.A. Pastorello. - In: THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1097-6825. - 6:5(2018), pp. 1637-1641.
Anxiety and Depression Effects during Drug Provocation Test
E.A. Pastorello
2018
Abstract
Background Drug provocation test (DPT) represents the gold standard for the diagnosis of drug allergy. A DPT can be performed in a single-blind placebo-controlled manner. In anxiety and depressive disorders, patients need to be evaluated to understand the nature of placebo reactions. Objective The aim of this study was to evaluate the psychological profile of patients with reactions to placebo during a DPT. Methods We consecutively enrolled patients with suspected drug allergy undergoing a DPT preceded by the administration of the placebo. All patients underwent the Hospital Anxiety and Depression Scale (HADS), a questionnaire aimed to identify anxiety and depression, before the challenge test. Results A total of 196 patients were enrolled into this study: 8 (4%) patients resulted positive to the DPT, 60 (30.6%) demonstrated anxiety or depression based on the HADS, and 54 had at least 1 placebo reaction during drug provocation. There were statically significant correlations between the positivity of the HADS and the finding of a placebo reaction (Fisher’s exact test: P < .001), and between the latter and a history of severe reactions to drug (Fisher’s exact test: P < .001). Conclusions There is a significant and strong correlation between the loss of psychic equilibrium and the development of a placebo reaction during a DPT. We suggest the use the HADS or other validated questionnaire in clinical practice before a DPT to evaluate the possible psychiatric components.File | Dimensione | Formato | |
---|---|---|---|
Anxiety and Depression Effects during Drug.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
487.45 kB
Formato
Adobe PDF
|
487.45 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.